Diwakar R. Pattabiraman, Ph.D.
Diwakar R. Pattabiraman, Ph.D.
Assistant Professor, Geisel School of Medicine at Dartmouth, Norris Cotton Cancer Center
Verified email at - Homepage
Cited by
Cited by
Emerging biological principles of metastasis
AW Lambert, DR Pattabiraman, RA Weinberg
Cell 168 (4), 670-691, 2017
Recovering gene interactions from single-cell data using data diffusion
D Van Dijk, R Sharma, J Nainys, K Yim, P Kathail, AJ Carr, C Burdziak, ...
Cell 174 (3), 716-729. e27, 2018
Tackling the cancer stem cells—what challenges do they pose?
DR Pattabiraman, RA Weinberg
Nature reviews Drug discovery 13 (7), 497-512, 2014
The systemic response to surgery triggers the outgrowth of distant immune-controlled tumors in mouse models of dormancy
JA Krall, F Reinhardt, OA Mercury, DR Pattabiraman, MW Brooks, ...
Science translational medicine 10 (436), eaan3464, 2018
Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability
DR Pattabiraman, B Bierie, KI Kober, P Thiru, JA Krall, C Zill, F Reinhardt, ...
Science 351 (6277), aad3680, 2016
Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells
B Bierie, SE Pierce, C Kroeger, DG Stover, DR Pattabiraman, P Thiru, ...
Proceedings of the National Academy of Sciences 114 (12), E2337-E2346, 2017
Role and potential for therapeutic targeting of MYB in leukemia
DR Pattabiraman, TJ Gonda
Leukemia 27 (2), 269-277, 2013
miR-139-5p is a regulator of metastatic pathways in breast cancer
K Krishnan, AL Steptoe, HC Martin, DR Pattabiraman, K Nones, ...
Rna 19 (12), 1767-1780, 2013
Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance
V Barbier, J Erbani, C Fiveash, JM Davies, J Tay, MR Tallack, J Lowe, ...
Nature Communications 11 (1), 1-15, 2020
Interaction of c-Myb with p300 is required for the induction of acute myeloid leukemia (AML) by human AML oncogenes
DR Pattabiraman, C McGirr, K Shakhbazov, V Barbier, K Krishnan, ...
Blood 123 (17), 2682-2690, 2014
Integrated genome-wide chromatin occupancy and expression analyses identify key myeloid pro-differentiation transcription factors repressed by Myb
L Zhao, EA Glazov, DR Pattabiraman, F Al-Owaidi, P Zhang, MA Brown, ...
Nucleic acids research 39 (11), 4664-4679, 2011
Targeting the epithelial-to-mesenchymal transition: the case for differentiation-based therapy
DR Pattabiraman, RA Weinberg
Cold Spring Harbor symposia on quantitative biology 81, 11-19, 2016
Phenotypic heterogeneity driven by plasticity of the intermediate EMT state governs disease progression and metastasis in breast cancer
MS Brown, B Abdollahi, OM Wilkins, H Lu, P Chakraborty, NB Ognjenovic, ...
Science advances 8 (31), eabj8002, 2022
Hypoxia inducible factor (HIF)-2α accelerates disease progression in mouse models of leukemia and lymphoma but is not a poor prognosis factor in human AML
CE Forristal, AL Brown, FM Helwani, IG Winkler, B Nowlan, V Barbier, ...
Leukemia 29 (10), 2075-2085, 2015
Mutations in multiple domains of c-Myb disrupt interaction with CBP/p300 and abrogate myeloid transforming ability
DR Pattabiraman, J Sun, DH Dowhan, S Ishii, TJ Gonda
Molecular Cancer Research 7 (9), 1477-1486, 2009
A functional SUMO-interacting motif in the transactivation domain of c-Myb regulates its myeloid transforming ability
T Sæther, DR Pattabiraman, AH Alm-Kristiansen, LT Vogt-Kielland, ...
Oncogene 30 (2), 212-222, 2011
A recessive screen for genes regulating hematopoietic stem cells
P Papathanasiou, R Tunningley, DR Pattabiraman, P Ye, TJ Gonda, ...
Blood 116 (26), 5849-5858, 2010
Vascular niche E-selectin protects acute myeloid leukaemia stem cells from chemotherapy
IG Winkler, V Barbier, DR Pattabiraman, TJ Gonda, JL Magnani, ...
Blood 124 (21), 620-620, 2014
Limiting Self-Renewal of the Basal Compartment by PKA Activation Induces Differentiation and Alters the Evolution of Mammary Tumors
NB Ognjenovic, M Bagheri, GA Mohamed, K Xu, Y Chen, MAM Saleem, ...
Developmental Cell 55 (5), 544-557. e6, 2020
Quantifying the epithelial-to-mesenchymal transition (EMT) from bench to bedside
MS Brown, KE Muller, DR Pattabiraman
Cancers 14 (5), 1138, 2022
The system can't perform the operation now. Try again later.
Articles 1–20